11 results
8-K
LIANY
LianBio
20 Dec 23
LianBio Announces Departure of Chief Financial Officer
8:05am
to the growth and success of the business during her tenure with the Company.
On December 19, 2023, the Company entered into a separation agreement
8-K
LIANY
LianBio
19 Dec 23
LianBio Announces Departure of Chief Executive Officer
4:26pm
tenure with the Company.
On December 16, 2023, the Company entered into a separation agreement with Dr. Wang (the “Separation Agreement”), pursuant
8-K
LIANY
LianBio
13 Dec 22
LianBio Announces President and Chief Strategy Officer Departure
5:03pm
and success of the business during her tenure with the Company.
On December 13, 2022, the Company entered into a separation agreement with Dr. Yu
S-3
EX-25.1
LIANY
LianBio
10 Nov 22
Shelf registration
5:26pm
, the Chairman, the President or such other authorized officer. Any person may hold two offices.
Section 4.6. Tenure of Office. The Chairman
DEFR14A
a4f9hroh138r8xk0h
28 Apr 22
Revised proxy
5:10pm
DEF 14A
ccx09ei8adslkq1wg
27 Apr 22
Definitive proxy
8:17am
8-K
EX-3.1
kpv4ln
3 Nov 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
S-1
EX-3.1
6l8afhd7
1 Oct 21
IPO registration
4:52pm
DRS
EX-3.1
s32tdfrshz
28 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next